Mitochondrial targeted AIEgen phototheranostics for bypassing immune barrier via encumbering mitochondria functions
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, Pai | - |
dc.contributor.author | Ren, Fei | - |
dc.contributor.author | Son, Subin | - |
dc.contributor.author | Ji, Myung Sun | - |
dc.contributor.author | Li, Peng | - |
dc.contributor.author | Cai, Zhengxu | - |
dc.contributor.author | Shi, Jianbing | - |
dc.contributor.author | Liu, Yi | - |
dc.contributor.author | Dong, Yuping | - |
dc.contributor.author | Kim, Jong Seung | - |
dc.date.accessioned | 2022-06-10T18:40:17Z | - |
dc.date.available | 2022-06-10T18:40:17Z | - |
dc.date.created | 2022-06-09 | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/141880 | - |
dc.description.abstract | Photodynamic therapy combined with immunogenic cell death has been proposed to overcome the unsolvable problems of single therapy, such as high levels of tumor recurrence and treatment resistance of tumors. Previous works on this theme have mostly concentrated on endoplasmic reticulum (ER)-stressed damage-associated molecular patterns (DAMPs), ignoring the secretion and function of mitochondria-related DAMPs. Herein, our work reports two intersystem crossing photosensitizers based on well-designed multiarylpyrrole structures and draws valuable attention to mitochondria-related DAMP-TFAM (mitochondrial transcription factor) when cancer cells are under forceful oxidative stress. The tumors vanished, and immunogenic experiments were applied to illuminate the advantages of double treatment. Our discovery of new mitochondria-related DAMPs compensates for the lack of ER-stressed DAMPs and offers an innovative target for immunity therapy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | IMMUNOGENIC CELL-DEATH | - |
dc.subject | PHOTODYNAMIC THERAPY | - |
dc.subject | CANCER | - |
dc.subject | APOPTOSIS | - |
dc.subject | RESPONSES | - |
dc.subject | STRESS | - |
dc.subject | DAMPS | - |
dc.title | Mitochondrial targeted AIEgen phototheranostics for bypassing immune barrier via encumbering mitochondria functions | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong Seung | - |
dc.identifier.doi | 10.1016/j.biomaterials.2022.121409 | - |
dc.identifier.scopusid | 2-s2.0-85124957752 | - |
dc.identifier.wosid | 000788727300002 | - |
dc.identifier.bibliographicCitation | BIOMATERIALS, v.283 | - |
dc.relation.isPartOf | BIOMATERIALS | - |
dc.citation.title | BIOMATERIALS | - |
dc.citation.volume | 283 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | IMMUNOGENIC CELL-DEATH | - |
dc.subject.keywordPlus | PHOTODYNAMIC THERAPY | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | STRESS | - |
dc.subject.keywordPlus | DAMPS | - |
dc.subject.keywordAuthor | Aggregation-induced emission photosensitizers | - |
dc.subject.keywordAuthor | Immunogenic cell death | - |
dc.subject.keywordAuthor | Mitochondria-related damage-associated mo- | - |
dc.subject.keywordAuthor | lecular patterns | - |
dc.subject.keywordAuthor | Immune barrier | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.